# Indacaterol + Glycopyrronium

## Ultibro Breezhaler 110/50mcg

| TAH Drug Code      | [EULT1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EULT1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Once-daily maintenance bronchodilator treatment to relieve symptoms & reduce exacerbations in patients with COPD.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Adult Dosing Chronic obstructive pulmonary disease: 1 capsule via INHALATION once a day using Ultibro Breezhaler inhaler. Safety and efficacy not established in children<18years.                                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | hypersensitivity to glycopyrrolate, indacaterol maleate, or any excipients of the product                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Cardiovascular: Chest pain (1% to less than 10% ) Endocrine metabolic: High glucose level in blood (4.1% ) Gastrointestinal: Indigestion (1% to less than 10% ) Neurologic: Dizziness (1% to less than 10% ), Headache (1% to less than 10% ) Respiratory: Cough (1% to less than 10% ), Nasopharyngitis (1% to less than 10% ), Pain in throat (1% to less than 10% .), Rhinitis (1% to less than 10% ), Sinusitis (1% to less than 10% ), Throat irritation, Upper respiratory infection (10% or more ) Other: Fever (1% to less than 10% ) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

